PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

On the road to growth!, page-17

  1. 281 Posts.
    lightbulb Created with Sketch. 107
    Yes I agree completely - to my mind the potential value here is for PPS to become a mass-market default treatment for OA, and possibly a range of other indications. For this to happen I think the strategy would probably be to get it out there to as many people as possible, as soon as possible, and not be too ambitious on the pricing.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.